0000950103-24-008516.txt : 20240618 0000950103-24-008516.hdr.sgml : 20240618 20240618212936 ACCESSION NUMBER: 0000950103-24-008516 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ADC Therapeutics SA CENTRAL INDEX KEY: 0001771910 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39071 FILM NUMBER: 241053851 BUSINESS ADDRESS: STREET 1: BIOPOLE STREET 2: ROUTE DE LA CORNICHE 3B CITY: EPALINGES STATE: V8 ZIP: 1066 BUSINESS PHONE: 41 21 653 02 00 MAIL ADDRESS: STREET 1: BIOPOLE STREET 2: ROUTE DE LA CORNICHE 3B CITY: EPALINGES STATE: V8 ZIP: 1066 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Azelby Robert CENTRAL INDEX KEY: 0001656998 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVE. NORTH, STE 300 CITY: SEATTLE STATE: WA ZIP: 98109 144 1 primary_doc.xml 144 0001656998 XXXXXXXX LIVE 0001771910 ADC Therapeutics SA 001-39071 430 Mountain Ave Suite 404 New Providence NJ 07974 908-440-7732 Robert Azelby Director Common Shares Morgan Stanley

1 New York Plaza 38th Floor New York NY 10004

6995 20215.55 53005 06/17/2024 NYSE Common Shares 06/14/2024 Vesting of Restricted Share Unit Grant ADC Therapeutics SA N 20000 06/14/2024 Vesting of Restricted Stock Unit Grant Y The Reporting Person is selling the securities set forth herein pursuant to an automatic "sell to cover" transaction that did not represent a discretionary trade by the Reporting Person in order to pay the tax liability arising from the vesting and settlement of restricted share units. 06/17/2024 /s/ Robert Azelby